Document ID: chunk:federal_register_of_legislation:F2020L01551:body:0:p11
Version: federal_register_of_legislation:F2020L01551
Segment Type: other
Provision Reference: 
Character Range: 33089–35891

subsidiaries.

          Columns 4, 5, 6, 7 and 8 of item 4.1 are derived as the sum of columns 4, 5, 6, 7 and 8 of item 4 respectively.

          Column 9 of item 4.1 is derived as the ratio of column 8 of item 4.1 to Tier 1 Capital reported in item 6.

Section C: Excluded exposures
Item 5  Report excluded exposures to a related entity, relating to settlement exposures, exceeding or equal to 10 per cent of Tier 1 Capital, as at the end of the reporting period.

        In column 1, report the related entity name for each exposure.

        In column 2, report the Legal Entity Identifier of the related entity for each exposure to a related entity. Otherwise, report N/A if the related entity has no Legal Entity Identifier.

        In column 3, report the related entity category of the related entity for each exposure.

        In column 4, report the related entity sector of the related entity for each exposure.

        In column 5, report the on-balance sheet exposures that relate to the book value of all loans and advances to the related entity.

        In column 6, report the on-balance sheet exposures that do not relate to loans and advances to the related entity for each exposure.

        In column 7, report the non-market related, off-balance sheet exposures for the related entity for each exposure.

        In column 8, report the market related, off-balance sheet exposures for the related entity for each exposure.

        Column 9 is derived as the total of columns 5, 6, 7 and 8 being the total exposure for the related entity.

        Column 10 is derived as the ratio of column 9 to Tier 1 Capital reported in item 6.

Memorandum Items
Item 6    Report in item 6 the Tier 1 Capital at Level 1 as at the end of the reporting period.
Item 7    Report in item 7 the aggregate exposure to all related ADIs, including overseas based equivalents.

Item 8    Report in item 8 the aggregate exposure to all related entities other than related ADIs and related overseas based equivalents.
Item 8.1  Report in item 8.1 the aggregate exposure to non-regulated related entities.

Section D: Substantial Shareholdings
Item 9   In column 1, report the substantial shareholder name.

         In column 2, report the Legal Entity Identifier of the substantial shareholder, if applicable. Otherwise, report N/A if the substantial shareholder has no Legal Entity Identifier.

         In column 3, report the substantial shareholder's percentage holding of the ADI's share capital.

Item 10  Report the movement of substantial shareholdings in the ADI where the movement during the quarter is equal to or greater than one percent of the shareholding.

         In column 1, report the substantial shareholder name.

         In column 2, report the